Business Context and Reporting Period
This Form 8-K is filed by Nukkleus Inc. (trading symbol: NUKK) on November 8, 2024, with the report date signed on November 15, 2024. The filing addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Global Market and a recent unregistered sale of equity securities.
Key Financial Metrics and Liquidity
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. However, it discloses specific debt and liquidity-related transactions:
- Debt Conversion: The company converted outstanding principal and interest totaling $771,085 owed to X Group Fund of Funds into equity.
- Equity Issuance: Following an amendment on November 14, 2024, the conversion resulted in the issuance of 319,952 shares of common stock.
- Warrant Terms: A warrant issued in connection with the conversion has an amended exercise price of $2.41 per share.
- Market Value Compliance: The company failed to maintain the required minimum market value of publicly held shares ($15 million) and total listed securities ($50 million) for 30 consecutive business days.
Material Changes and Events
The primary material change reported is the notice of delisting from The Nasdaq Global Market. On November 13, 2024, Nasdaq informed the company that it failed to comply with Listing Rules 5450(b)(2)(C) and 5450(b)(2)(A) regarding market value requirements. This follows an initial non-compliance notice issued on May 16, 2024, which granted an 180-day compliance period that expired on November 12, 2024, without the company regaining compliance.
Outlook, Risks, and Management Commentary
Appeal Process: Management intends to appeal the delisting determination to a Nasdaq Hearings Panel. A request for a hearing is planned for submission by November 20, 2024. This appeal will stay the suspension of securities and the filing of Form 25-NSE pending the Panel's decision.
Trading Status: During the appeal, common stock (NUKK) and warrants (NUKKW) will continue to trade on The Nasdaq Global Market.
Risks and Contingencies: The filing explicitly states there is no assurance that the Panel will grant the request for continued listing or that the company will be able to regain compliance with Nasdaq rules. Failure to maintain listing could result in trading on the OTC markets, potentially affecting liquidity and investor perception.
Investor Verification Checklist
- Verify the status of the Nasdaq Hearings Panel decision and the final listing status of NUKK and NUKKW.
- Confirm the exact number of shares issued to X Group Fund of Funds and the impact on total share count and dilution.
- Monitor future filings for updates on the company's ability to regain compliance with Nasdaq market value rules.
- Review the full text of the Letter Agreement (Exhibit 10.1) for additional covenants or terms related to the debt conversion.